We only have this paper's title and publication details.
Read it at the sourceObservational analysis reveals RNA alternative splicing promotes ovarian cancer progression, suggesting m6A modification inhibition may provide therapeutic avenues.
Sequences of shRNA oligos and antisense oligonucleotides used in the study.
No takes yet. Share an insight, caveat, or question.
Zuo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: